Inactive Instrument
CardieX Limited Stock OTC Markets
Stocks
CDEX.F
AU0000015729
Advanced Medical Equipment & Technology
OTC Markets Traded| Market Cap | 19.01M 13.63M 11.7M 10.98M 10.03M 18.92M 1.3B 130M 50.35M 656M 51.17M 50.06M 2.17B | P/E 2024 |
-2.06x | P/E 2025 | -0.78x |
|---|---|---|---|---|---|
| Enterprise Value | 20.21M 14.49M 12.43M 11.67M 10.66M 20.12M 1.38B 138M 53.52M 697M 54.39M 53.21M 2.31B | EV / Sales 2024 |
1.87x | EV / Sales 2025 | 3.83x |
| Free-Float |
68.31% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: CardieX Limited
| 24-07-17 | CardieX : Annual Report 202 | PU |
| 24-05-15 | CardieX : Stock Information | PU |
| 22-07-04 | CardieX : Application for quotation of securities - CDX | PU |
| 22-04-28 | CardieX : March Quarterly Activities Report | PU |
| 22-04-12 | CardieX : subsidiary files key regulatory submission for CONNEQT companion app | PU |
| Manager | Title | Age | Since |
|---|---|---|---|
Craig R. Cooper
CEO | Chief Executive Officer | - | - |
Sanjeev Bhavnani
CTO | Chief Tech/Sci/R&D Officer | - | 2024-02-29 |
Ahmad M. Qasem
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
R. Nelson
BRD | Director/Board Member | 69 | 2015-11-12 |
Craig R. Cooper
BRD | Director/Board Member | - | 2017-11-30 |
Niall Cairns
CHM | Chairman | 62 | 2019-02-26 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | +166.67% | - | - | 9.72M | |
| +0.88% | +3.31% | +29.76% | +16.26% | 232B | |
| -0.22% | +1.69% | +4.28% | -17.75% | 152B | |
| -0.56% | -7.11% | -22.10% | +22.54% | 131B | |
| -3.32% | -7.27% | -54.67% | -10.34% | 72.26B | |
| -1.11% | -1.80% | -16.89% | -14.19% | 51.57B | |
| +0.41% | -1.19% | +12.19% | +19.93% | 52.38B | |
| -0.80% | -1.57% | +29.31% | +27.56% | 43.71B | |
| -0.28% | -0.74% | +39.39% | +46.66% | 40.72B | |
| +0.01% | +9.82% | +128.03% | +42.31% | 33.97B | |
| Average | -0.43% | +3.90% | +16.59% | +14.78% | 90.01B | |
| Weighted average by Cap. | -0.23% | +3.71% | +9.52% | +10.06% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 12.81M 9.18M 7.88M 7.4M 6.76M 12.75M 876M 87.55M 33.93M 442M 34.48M 33.73M 1.46B | 6.05M 4.34M 3.72M 3.49M 3.19M 6.02M 414M 41.36M 16.03M 209M 16.29M 15.93M 691M |
| Net income | -6.77M -4.85M -4.16M -3.91M -3.57M -6.73M -462M -46.23M -17.91M -233M -18.21M -17.81M -773M | -18.19M -13.04M -11.19M -10.5M -9.59M -18.11M -1.24B -124M -48.18M -627M -48.96M -47.9M -2.08B |
| Net Debt | 3.35M 2.4M 2.06M 1.93M 1.76M 3.33M 229M 22.86M 8.86M 115M 9M 8.81M 382M | 1.2M 859K 737K 692K 632K 1.19M 81.92M 8.19M 3.17M 41.33M 3.22M 3.15M 137M |
Employees
-
